The Cancer Letter Archives
The Cancer Letter was founded in 1973, two years after Congress passed the National Cancer Act of 1971. These archives represent the first 40 years of The Cancer Letter, which is published weekly.
CCL
Vol.
35
No.
5
May 25, 2012
- ACCP and ASCO Publish Joint Guideline Following Review of Evidence on Low-Dose CT
- NIH Study Finds Sigmoidoscopy Reduces Colon Cancer Incidence and Mortality Rates
- Crizotinib Eliminated Tumors In 7 of 8 Children with ALCL
- Tivozanib Trumps Sorafenib In 1st-Line Renal Cancer Study
- Blinatumomab Shows Response In Adults with Refractory ALL
- Lenalidomide Maintenance Increased PFS and Survival
- 5-Day Strut-based Brachytherapy Produced Low Recurrence Rates
- Common Chemotherapy Fertilizes Marrow Before Tumors Take Root
- Study Identifies Characteristics That Promote Early-Life NHL
- Study Links Exercise and Survival In Breast and Colon Cancer Mortality
- Trials Approved by NCI CTEP For the Month of May
TCL
Vol.
38
No.
25
June 22, 2012
CCL
Vol.
35
No.
6
June 29, 2012
- Phase III Data of Antibody-Drug Conjugate Shows PFS Increase in HER2+ Disease
- Continous Hormone Therapy Superior To Intermittent In 17-Year SWOG Study
- Phase III Afatinib Trial Met Primary Endpoint In Stage IIIb or IV Cancer with EGFR Mutation
- Phase III Regorafenib Trial Meets PFS Primary Endpoint
- Radium-233 Dichloride Increased Overall Survival in Phase III Trial
- Zytiga Plus Prednisone Shows Improvement in PFS and OS Over Prednisone Alone
- Nexavar Phase III Trial Fails To Meet Primary Endpoint
- Alimta/Cisplatin Chemotherapy Increased Overall Survival
- New Carfilzomib Combination Produces Near Remissions
- Trial Data: No Benefit In Adding Perifosine to Capecitabine
- Blinatumomab Demonstrates High Response Rate in ALL
- MET Inhibitor Improved Time To Progression by 56 Percent
- NCI-Approved CTEP Trials For The Month of June